Prosperity Wind Facility
Sector: Commercial • Location: United States
Source: Latham & Watkins LLP
Apex Clean Energy has announced the tax equity financing of the 300 MW Prosperity Wind facility, which is scheduled to begin commercial operations in early 2025. Latham & Watkins LLP represented Apex Clean Energy in the project financing for this renewable energy project.
Project Information FAQ
Project Information
Want to explore the full details? View the full report
Participants
Sponsoring Agency | Obfuscated Data |
Company | Obfuscated Data |
Status
Original status | Planned |
Taiyo status | Obfuscated Data |
Taiyo last update | 00-00-0000 |
Available timestamps | 00-00-0000 |
Available timestamp type | Obfuscated Data |
Contact
Contact name | Obfuscated Data |
Phone | 0000000000 |
ObfuscatedData@email.com | |
Address | Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data |
Description
Description | Apex Clean Energy has announced the tax equity financing of the 300 MW Prosperity Wind facility, which is scheduled to begin commercial operations in early 2025. Latham & Watkins LLP represented Apex Clean Energy in the project financing for this renewable energy project. |
Original sub-sector | Obfuscated |
Original Currency | USD |
Original budget | 000000000000000 |
Procurement method | Obfuscated Data |
Budget | 000000000000000 |
Location
Region | Obfuscated |
Country | Obfuscated |
State | Obfuscated Data |
County | Obfuscated |
Location | Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data |
Source
Source reliability | High |
Data quality score | 100% |
Source | Obfuscated Data |
URL | obfuscated_data,obfuscateddata.com |
More Details
Project Type | Obfuscated Data |
Article Published Date | Obfuscated Data |
More Commercial projects in United States
- Engineering, Procurement, and Construction of Third Bosphorus Bridge
- Morphotek’s New Biologics Production Facility
- LabCentral 238, Cambridge, Massachusetts, USA
- Medical and Research Translation (MART) Building, Stony Brook University
- Kite Pharma’s Viral Vector Manufacturing Facility, California, US
- Virginia Cancer Specialists (VCS) Research Facility, Virginia
- Bristol-Myers Squibb Manufacturing Plant, Devens, Massachusetts
- Cambridge Major Laboratories Active Pharmaceutical
